Water-jel Neomycin Antibiotic Ointment
NDC Package 59898-730-01
Package Information
Water-jel Neomycin Antibiotic (first aid ointment) ointment is a medication used to decrease the risk of infection after certain intestinal surgeries. This formulation utilizes a ointment delivery system. Marketed by Water-jel Technologies, this product is identified by NDC 59898-730 and is authorized under FDA application M004.
Identification & Billing
- RxCUI: 311928 - neomycin 0.35 % Topical Ointment
- RxCUI: 311928 - neomycin 0.0035 MG/MG Topical Ointment
- RxCUI: 311928 - neomycin (as neomycin sulfate 5 MG per 1 GM) 3.5 MG per 1 GM Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 59898 - Water-jel Technologies
- 59898-730 - Water-jel Neomycin Antibiotic
- 59898-730-01 - 1728 PACKET in 1 CARTON / .9 g in 1 PACKET
- 59898-730 - Water-jel Neomycin Antibiotic
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (59898-730). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59898-730-01 identifies a specific commercial package of 1728 packet in 1 carton / .9 g in 1 packet of Water-jel Neomycin Antibiotic, a human over the counter drug labeled by Water-jel Technologies. This ointment is formulated for topical use and contains neomycin sulfate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Water-jel Technologies on March 31, 2010. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to decrease the risk of infection after certain intestinal surgeries. Neomycin belongs to a class of drugs known as aminoglycoside antibiotics. It works by stopping the growth of bacteria in the intestines. Neomycin may also be used along with a special diet to treat a certain serious brain problem (hepatic encephalopathy). This condition is caused by too much of a certain natural substance (ammonia). Normally, the liver gets rid of ammonia, but liver disease can cause too much ammonia to build up in the body. This medication helps treat encephalopathy by killing certain intestinal bacteria that make ammonia. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.
How is this Water-jel Technologies product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59898073001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.